Risk of breast cancer in male BRCA2 carriers

The risk of breast cancer for unaffected men who test positive for a BRCA2 mutation is based on very few retrospective studies. We have used both retrospective and prospective analysis in 321 families with pathogenic BRCA2 mutations. Three breast cancers occurred in male first-degree relatives after...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical genetics Vol. 47; no. 10; pp. 710 - 711
Main Authors Evans, D G R, Susnerwala, I, Dawson, J, Woodward, E, Maher, E R, Lalloo, F
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.10.2010
BMJ Publishing Group
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The risk of breast cancer for unaffected men who test positive for a BRCA2 mutation is based on very few retrospective studies. We have used both retrospective and prospective analysis in 321 families with pathogenic BRCA2 mutations. Three breast cancers occurred in male first-degree relatives after family ascertainment in 4140 years of follow-up suggesting a risk of breast cancer to 80 years of 8.9%. A second analysis excluding index cases identified 16 breast cancers in 905 first-degree male relatives on which Kaplan–Meier analysis was performed after assigning carrier status. This analysis confirmed that breast cancer risk in men was 7.1% (SE 5.2–8.6%) by age 70 years and 8.4% (SE 6.2–10.6%) by age 80 years.
Bibliography:href:jmedgenet-47-710.pdf
ark:/67375/NVC-85FDNNQ4-H
ArticleID:jmedgenet75176
local:jmedgenet;47/10/710
All authors contributed to the article.
istex:A75732245F63701CEFA19158E00E814DBB5905AD
PMID:20587410
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0022-2593
1468-6244
1468-6244
DOI:10.1136/jmg.2009.075176